Boston Biomedical, Inc. (Boston)

Oncology Corporate Profile

HQ Location

640 Memorial Drive
Cambridge, MA 2139

Company Description

Boston Biomedical, Inc. (Founder, President, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is wholly owned by Dainippon Sumitomo Pharma Co., Ltd. Boston Biomedical is focused on the research and development of novel cancer therapeutics, and has developed a world-leading product pipeline targeting cancer stem cells.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BB1608kinase inhibtorColorectal cancerIII
BB1608kinase inhibtorBreast cancerII
BB1608kinase inhibtorNon Small Cell Lung Cancer (NSCLC)II
BB1608kinase inhibtorVarious cancer typesII
BB1503kinase inhibtorGastric cancerI
BB1608kinase inhibtorPancreatic cancerI
BB1503kinase inhibtorVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display